基于数据挖掘及网络药理学探讨南北地域新型冠状病毒肺炎证候分布及用药规律
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R254

基金项目:

国家中医药管理局岐黄学者支持项目(2021年,国中医药人教涵〔2022〕6号);广东省中医药局科研项目(20212083);广东省中医院科研专项(E43643603)


Exploration on Syndrome Distribution and Medication Rules of COVID-19 in Northern and Southern China Based on Data Mining and Network Pharmacology
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:基于“因地制宜”理论,分析新型冠状病毒肺炎南北防治方案中的方药差异,阐明南北方 新冠肺炎证候规律,并探寻核心药物的作用机制。方法:检索文献数据库中各省市新型冠状病毒肺炎防治方 案。建立数据库进行统计学分析,按照地域划分为南北两部分,并分别进行数据挖掘分析,得出南北方不同的 证候方药规律,并运用网络药理学分析核心药物作用机制。结果:共检索到符合纳入标准的方案29篇。北方 地区符合纳入标准的有90首方剂,共得到132味中药,频数≥25次的核心药物共有8味。南方地区共有109首 方剂,共得到198味中药,频数≥25次的核心药物共有13味。北方地区证候中排名较前的为内闭外脱证、疫毒 闭肺证、气阴两虚证;南方地区证候排名较前的为内闭外脱证、湿热蕴肺证。经网络药理学分析预测核心药组 “麻黄-苦杏仁-甘草”治疗新型冠状病毒肺炎的关键基因为肿瘤坏死因子(TNF)、过氧化氢酶(CAT)、凝血 因子Ⅱ(F2);京都基因与基因组百科全书(KEGG) 通路富集分析结果排在前位的条目主要有新冠病毒致病通 路、FcεRI信号通路、Toll样受体(TLR) 信号通路等。结论:湿邪是新型号冠状病毒肺炎的核心致病因素, 北方侧重寒邪闭肺,南方侧重湿热困阻,而重症期均以“内闭外脱”为共性危象。核心药组“麻黄-苦杏仁- 甘草”可能通过作用于TNF、CAT、F2等靶点,调控TLR、FcεRI等信号通路而共同发挥治疗新冠病毒肺炎的 功效。

    Abstract:

    Abstract: Objective: Guided by the theory of "therapy customized to local conditions, " this study aims to analyze the differences in herbal prescriptions between COVID-19 prevention and treatment regimens issued in northern and southern China,elucidate the patterns of syndrome differentiation,and to investigate the mechanism of action of core herb combinations. Methods:Prevention and treatment regimens for COVID-19 from various provinces and cities were retrieved from literature databases. A database was established for statistical analysis. Data mining was conducted separately for the northern and southern regions to analyze the patterns of syndromes and herb prescriptions for COVID- 19. Network pharmacology was employed to analyze the mechanism of action of the core herbs. Results: A total of 29 regimens meeting the inclusion criteria were retrieved. In the northern region, 90 prescriptions met the criteria, involving 132 Chinese herbs. Eight core herbs with a frequency of use ≥25 times were identified. In the southern region, 109 prescriptions were included, involving 198 herbs, with 13 core herbs appearing ≥25 times. The most common syndromes identified in the northern region were internal blockage and external collapse syndrome, epidemic toxin blocking the lung syndrome, and deficiency of both qi and yin syndrome. In the southern region, the top syndromes were internal blockage and external collapse syndrome, and damp-heat accumulating in the lung syndrome. Network pharmacology analysis predicted that the key targets of the core herb combination "Ephedrae Herba-Armeniacae Semen Amarum-Glycyrrhizae Radix et Rhizoma" for treating COVID-19 were tumor necrosis factor (TNF),catalase (CAT), and F2 isoprostane (F2). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis indicated that the top pathways primarily included the Coronavirus disease-COVID-19 signaling pathway, Fc epsilon RI signaling pathway, and Toll-like receptor (TLR) signaling pathway. Conclusion: Pathogenic dampness is a core etiological factor in COVID-19. The syndrome type in the northern regions tended to be cold pathogen blocking the lung, while the in the southern regions tended to be damp-heat obstruction. However, the critical stage in both regions commonly manifests as "internal blockage and external collapse. " The core herb combination Ephedrae Herba- Armeniacae Semen Amarum-Glycyrrhizae Radix et Rhizoma may exert therapeutic effects by acting on targets such as TNF,CAT,and F2,and regulating signaling pathways like TLR and Fc epsilon RI.

    参考文献
    相似文献
    引证文献
引用本文

彭欧阳,李珮馨,李际强,刘洁娟,莫嘉浩,姚倚琦,张忠德.基于数据挖掘及网络药理学探讨南北地域新型冠状病毒肺炎证候分布及用药规律[J].新中医,2026,58(6):176-184

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-03-31
  • 出版日期:
文章二维码